Skip to main content


Weitere Artikel dieser Ausgabe durch Wischen aufrufen

01.06.2015 | short review | Ausgabe 2/2015

memo - Magazine of European Medical Oncology 2/2015

The role of positron emission tomography in breast cancer: a short review

memo - Magazine of European Medical Oncology > Ausgabe 2/2015
MD Maria Adele Marino, MD, MSc, MBA Univ. Prof. Thomas H. Helbich, MD Univ. Prof. Alfredo Blandino, MD, EBBI Assoc. Prof. Katja Pinker


Positron emission tomography (PET) provides information about abnormal metabolic features associated with cancer, and its role in breast cancer has been widely investigated. In the past several years, combined imaging systems, such as PET/CT and PET/MRI, and dedicated breast PET devices, such as PEM and MAMMI-PET, have been developed and implemented. These new techniques have become an effective oncologic tool for staging, re-staging, monitoring response to treatment, and estimation of the long-term prognosis. The aim of this review is to summarize the established and emerging PET imaging techniques and to discuss their value in the management of breast cancer patients.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Sie möchten Zugang zu diesem Inhalt erhalten? Dann informieren Sie sich jetzt über unsere Produkte:

Abo für kostenpflichtige Inhalte

Über diesen Artikel

Weitere Artikel der Ausgabe 2/2015

memo - Magazine of European Medical Oncology 2/2015 Zur Ausgabe